Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea
- Status
- COMPLETED
- Phase
- PHASE3
BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE3
Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe
- Status
- COMPLETED
- Phase
- N/A
Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant
- Status
- COMPLETED
- Phase
- N/A
Aripiprazole and Resistant Postpartum Depression
- Status
- COMPLETED
- Phase
- PHASE3
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments
- Status
- COMPLETED
- Phase
- N/A
Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
- Status
- COMPLETED
- Phase
- PHASE2
Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers
- Status
- UNKNOWN
- Phase
- PHASE1
Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
- Status
- TERMINATED
- Phase
- PHASE2
Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Biomarker Study (BMS-936558)
- Status
- COMPLETED
- Phase
- PHASE1
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)
- Status
- TERMINATED
- Phase
- PHASE2
Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden
- Status
- COMPLETED
- Phase
- PHASE2